Evidence reports Cell populations MAC.MDM.complement_resolving Gene expression
Static evidence for AI interpretation. These reports provide data for prompting AI and are not intended as a human-facing reading interface. Please visit the Cell Browser , Trait Browser and Genome Browser for interactive browsing. Have fun exploring SCREATE!
Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
MAC.MDM.complement_resolving: Gene expression
How association tiers are defined — cell–trait and gene–trait SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers Cell–trait links Identify cell types whose regulatory activity is associated with a trait’s genetic signal. Required for Specific or Relevant The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05. Specific (Tier 1) Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background. Relevant (Tier 2) Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types. Interpretation and report values CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance. Meta traits and individual traits Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier. Gene–trait priorities (variant–tCRE–gene evidence) Variant–tCRE–gene links Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model. Required genetic support The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2. Required cellular support The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority. High priority Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes. Medium priority Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score. Same-record evidence and aggregation Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule. Limits of interpretation A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,931 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
Meta traits · Individual traits · Gene expression · DE genes
Mean expression uses the current overview’s precomputed gene means from the displayed 10,000-cell sample, matching the overview gene-ranking panel. These are not full-population means and are not IC scores. Every gene with a finite value is included, including zero expression.
Rows 1–1,000 of 28,231; ranked by score descending. Equal values use name/identifier order.
Gene expression ranked for MAC.MDM.complement_resolving
Browsers # Gene Mean expression Meta traits (High Priority) Individual traits (High Priority)
1 CD74 5.04 13 14
2 FTL 4.80 5 6
3 FTH1 4.69 12 170
4 MALAT1 4.40 0 0
5 MT-ATP6 4.15 — —
6 MT-ATP8 4.15 — —
7 MT-CO3 4.15 — —
8 CST3 4.13 — —
9 HLA-DRB1 4.13 565 1,192
10 HLA-DRA 4.11 693 1,237
11 TMSB4X 4.07 — —
12 MT-CO2 4.06 — —
13 B2M 4.02 0 0
14 RPL10 3.98 — —
15 HLA-DPA1 3.83 287 545
16 TMSB10 3.80 1 1
17 EEF1A1 3.78 6 8
18 MT-CO1 3.74 — —
19 TPT1 3.68 0 0
20 MT-ND3 3.56 — —
21 MT-ND4 3.56 — —
22 MT-ND4L 3.56 — —
23 RPS12 3.43 3 3
24 RPLP1 3.43 0 0
25 ACTB 3.38 14 51
26 RPS27 3.37 11 53
27 VIM 3.37 32 102
28 HLA-DPB1 3.36 293 562
29 RPS24 3.34 0 0
30 RPL39 3.31 — —
31 RPL32 3.29 3 5
32 RPL28 3.25 3 3
33 RPL34 3.25 1 4
34 RPL11 3.23 0 0
35 FOS 3.22 3 3
36 SAT1 3.21 — —
37 RPL30 3.18 3 9
38 RPS28 3.18 72 402
39 RPS8 3.12 4 3
40 RPL13 3.11 11 21
41 RPL18A 3.10 4 6
42 RPS15A 3.09 1 1
43 RPL19 3.08 0 0
44 RPS3A 3.08 0 1
45 RPS23 3.04 0 2
46 RPS13 3.02 15 34
47 RPS14 2.96 5 5
48 RPL26 2.95 4 5
49 RPS27A 2.94 0 0
50 EIF1 2.92 0 0
51 RPS15 2.90 0 0
52 RPL37 2.88 3 4
53 TYROBP 2.87 7 9
54 PTMA 2.85 11 29
55 S100A4 2.85 2 2
56 MT-ND1 2.82 — —
57 RPS7 2.82 1 1
58 RPS19 2.79 1 2
59 RPLP0 2.76 3 7
60 FAU 2.73 8 10
61 RPL12 2.73 4 20
62 RPL15 2.73 0 0
63 C1QA 2.73 1 1
64 SELENOP 2.71 3 4
65 RPL8 2.71 1 3
66 HLA-DQA1 2.66 608 1,232
67 RPLP2 2.65 13 34
68 RPL29 2.64 1 10
69 MT-CYB 2.63 — —
70 RPL35A 2.62 0 0
71 RPS4X 2.62 — —
72 C1QC 2.61 1 1
73 RPS16 2.61 5 13
74 HLA-B 2.60 493 836
75 JUNB 2.58 9 31
76 RPL14 2.58 0 0
77 RPS3 2.55 0 0
78 RNASE1 2.54 4 4
79 SRGN 2.54 34 60
80 RPL18 2.53 3 4
81 S100A6 2.53 3 4
82 RPS18 2.53 17 39
83 IFI30 2.53 34 83
84 RPL6 2.52 0 0
85 RPS21 2.52 14 50
86 RPL41 2.49 2 2
87 PFN1 2.47 6 35
88 UBA52 2.44 37 60
89 RPL7A 2.44 107 152
90 ITM2B 2.43 1 4
91 HLA-DRB5 2.41 364 756
92 RPS6 2.38 1 1
93 RPL17 2.38 0 0
94 RPL17-C18orf32 2.38 0 0
95 RPS25 2.36 14 17
96 NACA 2.35 59 352
97 RACK1 2.33 0 0
98 DUSP1 2.33 12 46
99 RPS26 2.32 3 3
100 RPL5 2.31 0 0
101 GPX1 2.29 53 128
102 RPL22 2.29 8 181
103 RPL36A 2.27 — —
104 RPL36A-HNRNPH2 2.27 — —
105 RPS5 2.27 1 0
106 HLA-DQB1 2.27 703 1,314
107 PFDN5 2.26 0 0
108 RPS10 2.26 20 45
109 RPS10-NUDT3 2.26 20 45
110 RPS9 2.26 51 100
111 RPL21 2.25 0 0
112 RPS2 2.25 2 6
113 FCER1G 2.22 104 220
114 MYL6 2.19 3 6
115 OAZ1 2.19 12 28
116 HLA-DMA 2.17 226 330
117 PPIA 2.15 6 10
118 RPL36 2.15 1 11
119 CD14 2.13 22 52
120 NPC2 2.13 1 6
121 ARPC3 2.11 2 4
122 GAPDH 2.11 6 13
123 SH3BGRL3 2.09 18 62
124 PLAUR 2.08 34 60
125 HLA-C 2.06 738 1,070
126 RPL9 2.06 8 17
127 AIF1 2.06 433 801
128 CYBA 2.06 28 69
129 PABPC1 2.05 5 18
130 CFL1 2.05 24 101
131 RPL37A 2.04 6 10
132 LGALS1 2.03 22 66
133 RPL35 2.01 5 7
134 HSPA1A 2.01 81 205
135 LYZ 2.01 7 24
136 GABARAP 2.00 4 10
137 CALM2 1.99 1 1
138 RPL23A 1.98 — —
139 MS4A6A 1.97 38 78
140 S100A11 1.94 3 3
141 PSAP 1.94 40 65
142 UBC 1.91 23 137
143 RPS29 1.89 1 1
144 SERF2 1.88 11 22
145 RPL3 1.88 13 27
146 RPL24 1.87 10 36
147 RPL13A 1.84 70 205
148 S100A10 1.84 5 10
149 BTF3 1.83 0 0
150 ACTG1 1.82 9 27
151 COX4I1 1.79 3 7
152 CD68 1.79 33 81
153 CIRBP 1.79 0 0
154 HLA-A 1.79 281 510
155 GPX4 1.78 30 119
156 EEF1B2 1.77 6 9
157 LGALS3 1.76 7 33
158 ZFP36 1.76 1 0
159 EEF1D 1.76 5 14
160 RNASEK 1.76 23 53
161 RNASEK-C17orf49 1.76 23 53
162 MT-ND5 1.76 — —
163 HSPA8 1.75 5 26
164 CTSB 1.75 127 493
165 GPR183 1.74 11 28
166 CCNI 1.74 1 6
167 ARPC2 1.73 26 127
168 IFITM3 1.73 28 58
169 C1QB 1.72 1 1
170 EIF4A1 1.70 28 53
171 GADD45B 1.69 1 1
172 DDX5 1.69 5 16
173 RHOA 1.68 9 22
174 RPSA 1.66 7 12
175 GRN 1.66 12 23
176 EEF1G 1.65 10 27
177 RPL38 1.65 4 9
178 RPL31 1.63 0 0
179 CD63 1.62 0 0
180 BLVRB 1.61 12 44
181 LMNA 1.60 18 37
182 TIMP1 1.60 — —
183 YBX1 1.60 0 0
184 FCGR2B 1.60 209 293
185 BTG1 1.58 4 19
186 TPI1 1.57 9 19
187 RAC1 1.56 65 170
188 NR4A1 1.56 8 14
189 TUBA1B 1.55 0 0
190 SARAF 1.55 0 0
191 RPL10A 1.55 40 142
192 FXYD5 1.54 87 178
193 FOLR2 1.54 11 11
194 RPL4 1.54 2 3
195 CSTB 1.53 0 0
196 TSPO 1.52 13 39
197 ATF3 1.51 8 26
198 COX5B 1.50 — —
199 FCGRT 1.50 65 213
200 PPDPF 1.50 11 39
201 RGCC 1.50 1 4
202 TMA7 1.50 4 4
203 DAB2 1.49 39 81
204 SGK1 1.49 2 1
205 CDKN1A 1.48 19 29
206 KLF6 1.47 6 21
207 LAMTOR4 1.47 9 17
208 PNRC1 1.46 3 12
209 NPM1 1.46 3 5
210 ATP6V0C 1.45 2 6
211 RGS2 1.45 0 0
212 MT-ND2 1.45 — —
213 PCBP2 1.44 5 4
214 PPP1R15A 1.43 44 83
215 COX6B1 1.43 0 0
216 MIF 1.43 6 5
217 HCST 1.43 0 0
218 NFKBIA 1.42 8 22
219 RPL7 1.42 0 1
220 CFD 1.42 32 76
221 HSP90AB1 1.41 1 0
222 LAPTM5 1.40 16 38
223 HLA-E 1.40 193 384
224 COMMD6 1.39 0 0
225 TYMP 1.39 15 62
226 EEF2 1.39 13 22
227 NEAT1 1.39 23 70
228 DBI 1.38 5 10
229 CHMP1B 1.38 3 5
230 GLUL 1.38 7 67
231 MEF2C 1.38 33 42
232 SLC25A5 1.38 — —
233 SRP14 1.38 2 21
234 ZFP36L1 1.38 14 38
235 KLF4 1.38 0 0
236 HSP90AA1 1.37 2 8
237 JUN 1.37 0 0
238 ANXA1 1.36 2 2
239 UQCRB 1.36 0 0
240 NR4A2 1.35 1 1
241 ANXA2 1.34 8 11
242 ITGB2 1.34 45 135
243 TPM3 1.34 6 65
244 ANXA5 1.33 4 7
245 CEBPD 1.33 3 10
246 RPL27A 1.32 5 9
247 PPIB 1.31 3 8
248 MCL1 1.30 61 143
249 UBB 1.30 5 8
250 RNASET2 1.29 29 62
251 CRIP1 1.29 2 11
252 COTL1 1.28 17 66
253 MAP3K8 1.28 4 11
254 C1orf162 1.27 1 3
255 NDUFA11 1.27 21 23
256 NCF4 1.26 7 38
257 EIF3K 1.26 28 47
258 ATP6V0B 1.26 2 4
259 SEC61B 1.26 0 0
260 HNRNPDL 1.26 0 0
261 CTSD 1.25 14 22
262 ELOB 1.25 3 12
263 VAMP8 1.25 38 110
264 DNAJB1 1.25 1 5
265 SUMO2 1.25 7 21
266 UQCR11 1.24 1 1
267 HMGB1 1.24 0 0
268 SUB1 1.24 0 0
269 GSTP1 1.23 6 3
270 OST4 1.23 6 10
271 C5AR1 1.22 4 9
272 HNRNPA1 1.22 13 14
273 RHOB 1.21 1 1
274 ARPC1B 1.21 27 109
275 BLOC1S1 1.21 0 3
276 GNG5 1.21 2 2
277 SPI1 1.20 — —
278 AP1S2 1.20 — —
279 TUBB4B 1.19 4 6
280 ASAH1 1.19 25 50
281 MS4A4A 1.19 41 76
282 RPL36AL 1.19 2 2
283 TAGLN2 1.17 13 26
284 MS4A14 1.17 79 127
285 MS4A7 1.17 79 121
286 DNAJA1 1.17 6 8
287 RBM3 1.16 — —
288 CTSL 1.16 2 3
289 TXNIP 1.15 — —
290 SNRPD2 1.15 15 53
291 YWHAZ 1.15 2 2
292 LGMN 1.15 6 6
293 SDCBP 1.14 12 25
294 CALR 1.13 15 25
295 CD83 1.13 6 7
296 IFITM2 1.13 53 160
297 NDUFA13 1.12 62 193
298 MAFB 1.11 4 11
299 RGS10 1.11 8 23
300 FCGR2A 1.11 192 263
301 EIF4A3 1.11 11 32
302 HSP90B1 1.11 4 2
303 CLEC7A 1.11 7 9
304 HERPUD1 1.11 55 393
305 CORO1A 1.10 14 39
306 HMGN1 1.10 0 3
307 RPL22L1 1.10 47 158
308 ZFAS1 1.10 7 21
309 COX6C 1.10 0 0
310 CTSC 1.10 11 29
311 SEC11A 1.09 2 2
312 CXCL8 1.09 2 6
313 EDF1 1.08 15 25
314 CRTAP 1.08 7 16
315 PCBP1 1.08 0 0
316 PLTP 1.07 18 36
317 NME2 1.07 0 1
318 RPS4Y1 1.07 — —
319 MYL12B 1.07 1 3
320 VAPA 1.07 2 5
321 MYL12A 1.06 1 3
322 RPS11 1.05 59 186
323 CLIC1 1.04 159 256
324 TOMM7 1.04 3 11
325 STMN1 1.04 0 0
326 ALDOA 1.04 10 19
327 CTSS 1.04 129 340
328 SAP18 1.03 1 1
329 SQSTM1 1.03 8 10
330 SNX6 1.03 4 5
331 IER3 1.03 247 484
332 RPS20 1.02 11 38
333 TUBB 1.02 165 310
334 WDR83OS 1.02 14 33
335 COX7B 1.01 — —
336 ZNF331 1.01 1 1
337 FABP5 1.01 2 0
338 CD163 1.01 0 0
339 PTCD1 1.01 14 69
340 SERTAD1 1.01 7 24
341 CLEC10A 1.00 20 20
342 GMFG 0.99 1 1
343 COX6A1 0.99 15 33
344 TMEM14C 0.99 0 0
345 RNF130 0.99 7 10
346 SEM1 0.99 0 0
347 SLC25A3 0.99 1 2
348 COX7C 0.99 0 0
349 ARL4A 0.98 0 0
350 CALM1 0.98 1 1
351 BRK1 0.98 5 4
352 NDUFA3 0.98 7 7
353 TRAPPC5 0.98 14 15
354 HLA-DMB 0.97 224 330
355 ZYX 0.97 6 10
356 TMEM258 0.96 77 275
357 USP15 0.96 1 1
358 HSPA1B 0.96 60 376
359 N4BP2L2 0.96 0 0
360 UBXN1 0.96 1 1
361 UBL5 0.96 0 0
362 GRINA 0.95 48 90
363 RILPL2 0.95 24 92
364 SH3BGRL 0.95 — —
365 HSPD1 0.95 0 0
366 SKP1 0.94 1 1
367 CPVL 0.94 3 3
368 RPS17 0.94 0 0
369 ZFP36L2 0.94 39 140
370 CD37 0.94 8 15
371 HINT1 0.94 3 8
372 LSP1 0.93 41 132
373 HSPB1 0.93 1 0
374 HMOX1 0.93 2 1
375 FCN1 0.93 5 6
376 RPL27 0.93 0 0
377 CTSH 0.93 26 31
378 EMP3 0.93 0 0
379 SNX3 0.93 0 0
380 SPCS1 0.93 7 23
381 COX7A2 0.92 0 0
382 YWHAB 0.92 15 30
383 CREM 0.92 0 0
384 CAP1 0.92 6 15
385 F13A1 0.91 5 8
386 GPSM3 0.91 358 590
387 MAP1LC3B 0.91 4 4
388 LY96 0.91 3 3
389 EIF3I 0.91 0 0
390 COX8A 0.91 0 0
391 SF3B5 0.91 3 9
392 GNAS 0.90 21 84
393 LILRB5 0.90 96 158
394 NFE2L2 0.90 2 4
395 FABP4 0.90 3 1
396 SOD2 0.90 29 53
397 HNRNPA2B1 0.90 0 0
398 TMED10 0.90 2 3
399 LY86 0.89 12 21
400 DYNLL1 0.89 26 74
401 LST1 0.89 183 440
402 INSIG1 0.89 8 15
403 RASSF4 0.89 1 0
404 SON 0.89 0 0
405 PRDX1 0.89 1 2
406 ARL6IP1 0.88 1 1
407 HMGN2 0.88 0 0
408 FUS 0.88 4 11
409 FOSB 0.88 10 20
410 NDUFA4 0.88 0 0
411 CXCL16 0.88 19 69
412 FKBP1A 0.87 5 6
413 ENO1 0.86 8 26
414 TUBA1A 0.86 4 5
415 EIF3M 0.86 0 0
416 RPL23 0.86 3 9
417 MSR1 0.86 12 12
418 ARF1 0.86 0 0
419 EGR1 0.85 1 1
420 GSTK1 0.85 6 11
421 RSRP1 0.85 0 0
422 HSPE1 0.85 0 2
423 HSPE1-MOB4 0.85 0 2
424 MFSD1 0.85 4 8
425 CKS2 0.85 0 0
426 GDI2 0.85 5 13
427 SOD1 0.84 1 2
428 PGK1 0.84 — —
429 SRSF2 0.84 1 5
430 GNB2 0.84 31 93
431 IFNGR2 0.83 7 12
432 SRSF5 0.83 6 15
433 WSB1 0.83 — —
434 CHCHD2 0.83 12 30
435 PSME1 0.83 0 0
436 NCF1 0.83 10 24
437 TSC22D3 0.83 — —
438 PPCS 0.82 0 0
439 GRB2 0.82 17 45
440 AKR1A1 0.82 4 6
441 PID1 0.82 8 10
442 TMBIM6 0.82 9 15
443 EID1 0.81 0 0
444 TMEM14B 0.81 0 0
445 UBE2D3 0.81 11 17
446 SELENOH 0.81 22 55
447 PPP1CA 0.81 6 27
448 CLEC2B 0.81 2 3
449 REL 0.81 15 34
450 AP2S1 0.80 25 37
451 EIF3L 0.80 0 0
452 PEBP1 0.80 0 3
453 NINJ1 0.80 37 41
454 PLIN2 0.80 4 7
455 DAZAP2 0.80 5 7
456 UQCR10 0.80 7 18
457 C3AR1 0.80 4 4
458 RAB5C 0.80 19 54
459 WASF2 0.79 7 14
460 DUSP2 0.79 — —
461 CHCHD10 0.79 9 35
462 FYB1 0.79 16 33
463 VSIG4 0.79 — —
464 GYPC 0.79 3 4
465 CCNH 0.79 2 3
466 FIS1 0.79 16 22
467 SRRM1 0.79 15 59
468 CXCL2 0.79 12 42
469 EIF5 0.78 6 37
470 PRDX3 0.78 0 0
471 RHOG 0.78 9 22
472 ARHGDIB 0.78 3 8
473 TIAL1 0.78 11 32
474 MAT2A 0.78 14 46
475 IFRD1 0.78 1 18
476 ARRB2 0.78 14 58
477 PSMB6 0.77 7 9
478 CD44 0.77 4 5
479 NDUFB11 0.77 — —
480 SNHG12 0.77 0 0
481 BNIP3L 0.77 0 10
482 ATP6V1F 0.77 14 34
483 TMEM59 0.77 0 0
484 HNRNPU 0.76 0 0
485 SAMSN1 0.76 11 22
486 DDAH2 0.76 146 231
487 ID2 0.76 1 2
488 ARL6IP5 0.76 0 0
489 LGALS9 0.76 — —
490 CDC37 0.76 28 65
491 NAMPT 0.76 4 10
492 APMAP 0.75 — —
493 CKLF 0.75 7 8
494 CKLF-CMTM1 0.75 14 14
495 SERP1 0.75 1 0
496 COMT 0.75 9 9
497 PRDX5 0.75 4 34
498 RTN4 0.75 11 63
499 PGLS 0.75 6 6
500 PIGX 0.75 9 30
501 TRIR 0.75 0 0
502 CAPZB 0.75 20 47
503 PARK7 0.75 11 14
504 KRTCAP2 0.74 3 4
505 MGST3 0.74 0 0
506 DNAJB6 0.74 0 1
507 ATP6V1G1 0.74 14 19
508 ERGIC3 0.73 9 8
509 FLOT1 0.73 278 593
510 MEF2A 0.73 4 6
511 DPP7 0.73 36 71
512 OSTF1 0.73 1 1
513 NBPF10 0.73 48 127
514 SLC2A3 0.73 6 6
515 UBE2B 0.73 0 0
516 MRPS21 0.73 27 91
517 LAIR1 0.72 55 110
518 RASGEF1B 0.72 0 0
519 NDUFA1 0.72 — —
520 SCAMP2 0.72 6 13
521 CSRNP1 0.72 16 48
522 SNHG8 0.72 0 0
523 PDK4 0.72 5 8
524 UQCRQ 0.72 20 31
525 CSF1R 0.72 19 43
526 DOK2 0.72 20 88
527 SYK 0.72 5 24
528 RNASE6 0.72 6 6
529 FRMD4B 0.71 4 6
530 SELENOK 0.71 1 1
531 EIF3E 0.71 5 18
532 PRR13 0.70 3 2
533 ARHGAP4 0.70 — —
534 TBCA 0.70 1 2
535 THBD 0.70 0 0
536 ABHD12 0.70 0 0
537 VDAC2 0.70 0 0
538 CDC42 0.70 9 24
539 HDLBP 0.70 75 211
540 SLC3A2 0.70 1 2
541 TGFBI 0.69 9 12
542 LIPA 0.69 13 35
543 PAK2 0.69 4 7
544 SRSF7 0.69 1 0
545 PSMA6 0.69 7 15
546 DUSP6 0.69 29 40
547 CALM3 0.69 6 12
548 TXN 0.69 0 0
549 CIB1 0.68 11 27
550 GAS6 0.68 6 25
551 RBKS 0.68 140 286
552 CCNL1 0.68 13 23
553 IFNGR1 0.68 0 0
554 JMJD1C 0.68 290 935
555 SDHC 0.68 11 16
556 POLR2L 0.68 13 31
557 PSME2 0.68 6 9
558 ENY2 0.68 0 0
559 PSMA7 0.68 3 9
560 COX5A 0.67 3 6
561 RNH1 0.67 4 15
562 RGS1 0.67 7 12
563 NDUFB5 0.67 0 0
564 EIF1B 0.67 0 0
565 ARHGAP18 0.67 0 0
566 SF3B1 0.67 5 50
567 C9orf72 0.67 3 8
568 PTGES3 0.67 17 263
569 ATP6V0D1 0.67 31 79
570 SYNGR2 0.67 17 71
571 LTA4H 0.67 2 2
572 SSR3 0.67 4 6
573 HMGN3 0.67 0 0
574 TBXAS1 0.67 5 10
575 SLX1B 0.67 0 0
576 CD302 0.67 13 43
577 NDUFS5 0.66 3 2
578 SLC7A7 0.66 22 46
579 HIF1A 0.66 0 0
580 CD9 0.66 2 6
581 NDUFB7 0.65 0 0
582 EIF3F 0.65 0 0
583 PPP1CC 0.65 5 6
584 KHDRBS1 0.65 0 0
585 MORF4L1 0.65 36 97
586 SERPINB1 0.65 7 12
587 ACP5 0.65 6 8
588 ARGLU1 0.65 1 2
589 IFI16 0.65 9 21
590 TNFAIP2 0.64 17 47
591 IRF2BP2 0.64 10 25
592 LDHA 0.64 3 10
593 ANP32B 0.64 8 18
594 ARPC5 0.64 19 30
595 RBM39 0.64 0 0
596 ARF4 0.64 14 16
597 POMP 0.64 2 2
598 COPE 0.64 20 132
599 PSMB9 0.64 227 422
600 NDFIP1 0.64 11 47
601 APEX1 0.64 — —
602 PAPSS2 0.64 1 2
603 PTPRC 0.64 14 91
604 RAB7A 0.64 23 58
605 TUFM 0.63 13 101
606 HIGD2A 0.63 1 1
607 APRT 0.63 15 43
608 SSR4 0.63 — —
609 DAD1 0.63 22 43
610 SRSF3 0.63 17 22
611 HM13 0.63 — —
612 GLUD1 0.63 16 42
613 TCEA1 0.63 — —
614 IGF1 0.63 36 77
615 ZNF706 0.63 0 0
616 SLC40A1 0.63 7 12
617 NDUFB9 0.62 52 299
618 TMEM50A 0.62 0 0
619 UQCRC1 0.62 1 0
620 FGL2 0.62 2 2
621 BSG 0.62 2 2
622 TECR 0.62 0 0
623 ACTR3 0.62 0 0
624 ZRANB2 0.62 0 0
625 HNMT 0.62 2 2
626 C19orf53 0.62 6 21
627 GABARAPL2 0.62 1 1
628 VPS13C 0.61 1 2
629 ALG13 0.61 — —
630 EMC4 0.61 0 0
631 NDUFB8 0.61 0 0
632 NAPA 0.61 3 6
633 PABPC4 0.61 6 19
634 SPG21 0.61 1 2
635 SEC62 0.61 0 0
636 MTSS1 0.61 1 1
637 NCL 0.61 3 1
638 HSBP1 0.61 36 80
639 LRRFIP1 0.60 7 16
640 GLIPR1 0.60 0 1
641 ATP1B3 0.60 7 25
642 CCT2 0.60 3 8
643 CD47 0.60 5 18
644 CALCOCO2 0.60 14 25
645 PKN2 0.60 0 0
646 TRMT112 0.60 8 40
647 NOP53 0.60 5 9
648 LAMTOR5 0.60 1 0
649 FAAP20 0.60 27 106
650 PSMB1 0.60 0 0
651 SMDT1 0.60 6 7
652 PNP 0.60 — —
653 C11orf58 0.59 3 5
654 SFPQ 0.59 0 0
655 NDUFB2 0.59 0 0
656 RB1 0.59 0 1
657 JUND 0.59 32 94
658 CSNK2B 0.59 54 128
659 RAB31 0.59 2 5
660 COX7A2L 0.59 1 2
661 GPS2 0.59 17 19
662 G0S2 0.59 8 30
663 UFC1 0.59 2 2
664 SSR2 0.59 3 8
665 MYADM 0.59 19 22
666 SUPT4H1 0.59 16 52
667 LITAF 0.59 23 36
668 SNX2 0.59 5 16
669 HNRNPK 0.58 9 28
670 EIF4A2 0.58 54 101
671 CRYL1 0.58 0 0
672 SGMS1 0.58 4 6
673 ATRX 0.58 — —
674 SMARCA2 0.58 1 1
675 AHNAK 0.58 15 31
676 ARL6IP4 0.58 56 176
677 RHOC 0.58 29 113
678 PRH1 0.58 1 4
679 SDHB 0.57 2 4
680 CTNNB1 0.57 2 2
681 POLD4 0.57 6 11
682 PRMT2 0.57 3 3
683 U2AF1 0.57 0 0
684 IDH2 0.57 6 17
685 SUMO1 0.57 4 4
686 LDHB 0.57 18 32
687 STAT3 0.57 38 73
688 MGAT1 0.57 10 14
689 PTPRE 0.57 0 0
690 ARHGDIA 0.57 2 2
691 EVI2B 0.57 — —
692 ILF3 0.57 4 25
693 YPEL5 0.57 1 6
694 UBE2E2 0.57 0 0
695 LACTB 0.56 52 213
696 SEC14L1 0.56 0 1
697 CNIH4 0.56 1 2
698 TGIF1 0.56 2 5
699 CAPZA2 0.56 13 69
700 MOB1A 0.56 2 7
701 NOP10 0.56 0 0
702 PLD3 0.56 7 17
703 RNF7 0.56 5 17
704 CUTA 0.56 19 40
705 RAP1B 0.56 0 0
706 NDUFV2 0.56 4 6
707 RSU1 0.56 6 22
708 MAPRE1 0.56 8 25
709 MEA1 0.56 6 38
710 TMEM256 0.56 4 6
711 GLA 0.56 — —
712 LAPTM4A 0.56 14 22
713 TCF25 0.56 19 48
714 SRI 0.56 0 0
715 STAB1 0.56 120 362
716 GABARAPL1 0.56 2 2
717 PSMB3 0.56 1 3
718 TMEM176B 0.56 39 71
719 NCOA2 0.55 0 1
720 RWDD1 0.55 0 1
721 FCER1A 0.55 34 50
722 TMBIM4 0.55 2 3
723 SSB 0.55 3 2
724 ZFAND5 0.55 0 0
725 APOC1 0.55 301 1,434
726 CSTA 0.55 16 57
727 SAMHD1 0.55 9 18
728 SERPINB6 0.55 7 12
729 COX17 0.55 2 2
730 PRNP 0.55 1 2
731 SSBP1 0.55 0 0
732 SRRM2 0.55 3 2
733 LINC-PINT 0.55 37 125
734 RAN 0.55 1 2
735 GTF2B 0.55 1 1
736 APLP2 0.54 0 0
737 SCO2 0.54 10 50
738 DRAM2 0.54 4 12
739 PRELID1 0.54 71 149
740 TNFAIP3 0.54 19 50
741 CYTIP 0.54 2 3
742 NDUFA2 0.54 10 12
743 NDUFS3 0.54 — —
744 ANKRD10 0.54 1 3
745 CLTA 0.54 3 3
746 NEU1 0.54 26 37
747 HAVCR2 0.54 23 87
748 NRROS 0.54 9 29
749 IL1B 0.54 15 58
750 PKM 0.54 0 0
751 SRGAP2B 0.54 — —
752 TALDO1 0.54 2 5
753 PLEK 0.53 27 52
754 JAK1 0.53 15 51
755 PET100 0.53 5 5
756 HCLS1 0.53 18 46
757 SNRPD3 0.53 9 14
758 HSPA5 0.53 0 0
759 PRR4 0.53 0 0
760 TAS2R14 0.53 0 4
761 AREG 0.53 2 6
762 FAM204A 0.53 0 0
763 PDIA3 0.53 7 8
764 MTCH1 0.53 6 14
765 ELMO1 0.53 12 59
766 IRF7 0.53 11 28
767 VAMP2 0.53 10 21
768 IRF2 0.53 1 5
769 DCAF16 0.53 1 1
770 NBL1 0.53 22 52
771 PAFAH1B1 0.53 6 13
772 SLX1A 0.53 0 0
773 PLIN3 0.53 9 12
774 CYBB 0.52 — —
775 MPP1 0.52 — —
776 CMTM6 0.52 1 1
777 EWSR1 0.52 0 0
778 VCP 0.52 4 22
779 SNAP23 0.52 0 1
780 CD151 0.52 20 58
781 SIGLEC1 0.52 22 44
782 OLR1 0.52 3 4
783 OSTC 0.52 0 0
784 ANAPC16 0.52 0 1
785 SIVA1 0.52 44 128
786 UQCRH 0.52 3 8
787 ATOX1 0.52 1 4
788 CAT 0.52 1 1
789 IVNS1ABP 0.52 0 0
790 PHF11 0.52 2 4
791 PEA15 0.52 0 0
792 HEXB 0.52 0 0
793 ESD 0.51 — —
794 PILRA 0.51 28 67
795 SERINC1 0.51 0 2
796 TMEM106A 0.51 15 46
797 TMEM243 0.51 0 0
798 MRC1 0.51 5 7
799 NT5C3A 0.51 5 7
800 PSMA5 0.51 6 6
801 EPB41L3 0.51 1 1
802 SCRN1 0.51 0 0
803 HMGCL 0.51 2 3
804 SRPRA 0.51 14 15
805 ALDH2 0.51 51 130
806 MAPKAPK5-AS1 0.51 13 47
807 NR3C1 0.51 5 10
808 DYNLRB1 0.51 0 0
809 RBPJ 0.51 3 3
810 SLC1A3 0.51 0 0
811 RHEB 0.51 4 7
812 PDHB 0.50 5 8
813 POLR1D 0.50 1 1
814 RGL1 0.50 19 31
815 ST13 0.50 0 0
816 POLR2E 0.50 27 125
817 TMED2 0.50 9 19
818 RANBP2 0.50 2 1
819 CTNNA1 0.50 3 3
820 NUCB1 0.50 29 58
821 RNF213 0.50 4 6
822 IFI44 0.50 7 47
823 TTC1 0.50 0 0
824 MAN2B1 0.50 14 26
825 NR4A3 0.50 0 0
826 NRP2 0.50 6 5
827 MRPL54 0.50 0 0
828 OSBPL9 0.50 1 1
829 NDUFS6 0.50 0 0
830 APPL1 0.50 8 10
831 MT2A 0.50 10 12
832 SELENOF 0.50 1 1
833 UCP2 0.50 1 1
834 TNFRSF1A 0.50 22 43
835 SMIM29 0.49 10 22
836 ARL8B 0.49 1 1
837 C4orf3 0.49 4 7
838 AMD1 0.49 0 1
839 RSL1D1 0.49 2 2
840 MEAF6 0.49 2 5
841 DUSP22 0.49 13 26
842 LPAR6 0.49 0 0
843 ANAPC11 0.49 1 0
844 WWP1 0.49 0 0
845 CHCHD7 0.49 8 32
846 ANXA11 0.49 24 45
847 CFP 0.49 — —
848 CISD2 0.49 10 25
849 ZNF385A 0.49 94 96
850 PRCP 0.49 1 1
851 PARVB 0.49 35 46
852 PAXX 0.49 1 1
853 NASP 0.49 1 2
854 PNKP 0.49 9 21
855 TWF2 0.49 72 151
856 MANBA 0.49 42 95
857 CNBP 0.49 4 11
858 NCK1 0.49 35 67
859 NEDD8 0.49 4 5
860 NEDD8-MDP1 0.49 4 5
861 SRSF10 0.49 0 0
862 ARF5 0.49 5 8
863 DRAP1 0.49 21 40
864 LPXN 0.49 7 17
865 ETV6 0.49 5 13
866 ISCU 0.49 13 22
867 PIAS1 0.48 0 1
868 BAZ1A 0.48 11 27
869 LAMTOR1 0.48 1 1
870 HLA-DQA2 0.48 173 495
871 CSNK1D 0.48 7 24
872 KLF2 0.48 52 119
873 AKIRIN2 0.48 0 0
874 EIF2A 0.48 0 1
875 ARPC1A 0.48 15 71
876 CTSZ 0.48 8 56
877 TMEM208 0.48 4 5
878 NAGK 0.48 2 2
879 SEC13 0.48 1 1
880 NUP214 0.48 0 0
881 TBC1D7 0.48 3 2
882 AGPAT4 0.48 2 4
883 FAM200B 0.48 2 2
884 KLF3 0.48 13 41
885 SPAG9 0.48 0 0
886 UBXN4 0.48 0 0
887 ARPC4 0.48 1 1
888 ARPC4-TTLL3 0.48 1 1
889 DAGLB 0.48 63 137
890 TMEM230 0.48 0 0
891 HADHA 0.48 5 8
892 RNPEP 0.48 15 36
893 PGD 0.48 4 7
894 MCTP1 0.47 1 1
895 RABGEF1 0.47 0 0
896 HSD17B11 0.47 85 337
897 LSM3 0.47 9 17
898 TMEM70 0.47 7 7
899 HNRNPA3 0.47 2 4
900 PPP1R12A 0.47 3 3
901 OGFR 0.47 2 5
902 POLR2J2 0.47 0 0
903 CNN2 0.47 27 139
904 NDUFC2 0.47 13 30
905 NDUFC2-KCTD14 0.47 13 30
906 ACADVL 0.47 7 41
907 RANBP1 0.47 8 9
908 PLSCR1 0.47 2 2
909 SNX9 0.47 1 1
910 LINC01480 0.47 0 0
911 MRPS5 0.47 — —
912 STX11 0.47 1 2
913 MAP7D1 0.47 5 9
914 EIF3G 0.47 5 7
915 EPS8 0.47 1 1
916 CYTH2 0.47 3 3
917 SRP9 0.47 3 3
918 LYVE1 0.47 5 10
919 CD55 0.47 6 9
920 NDUFB4 0.47 0 0
921 SUCLG2 0.46 0 0
922 CYCS 0.46 — —
923 LAMP1 0.46 16 35
924 BCAP31 0.46 — —
925 NRDC 0.46 1 0
926 UBE2A 0.46 — —
927 GSK3B 0.46 38 80
928 EIF3CL 0.46 0 0
929 GHITM 0.46 0 0
930 DOCK2 0.46 1 1
931 MS4A4E 0.46 63 119
932 AUP1 0.46 2 4
933 CMKLR1 0.46 2 12
934 ATP1A1 0.46 2 1
935 WDR1 0.46 15 36
936 SEC61G 0.46 3 3
937 TNFSF13B 0.46 1 0
938 BLVRA 0.46 3 3
939 GNG2 0.46 1 1
940 EFCAB2 0.46 0 0
941 LAP3 0.46 2 2
942 SPINT2 0.46 11 25
943 XRCC5 0.46 5 9
944 CCDC12 0.46 37 56
945 SERPING1 0.46 26 78
946 LUC7L2 0.45 0 1
947 LILRB2 0.45 89 145
948 PSMD7 0.45 18 35
949 P4HB 0.45 9 16
950 C1D 0.45 10 11
951 ZEB2 0.45 3 5
952 AP2M1 0.45 1 1
953 SMIM19 0.45 — —
954 TPD52L2 0.45 8 20
955 IL13RA1 0.45 — —
956 VSIR 0.45 47 94
957 DIP2A 0.45 19 53
958 EMP1 0.45 5 13
959 SERPINB9 0.45 10 18
960 VASP 0.45 27 117
961 KDELR1 0.45 1 1
962 RNF144B 0.45 9 25
963 ATRAID 0.45 85 481
964 C12orf57 0.45 0 0
965 EIF5A 0.45 7 13
966 BID 0.45 10 10
967 SSRP1 0.45 20 44
968 UXT 0.45 — —
969 BCKDK 0.45 39 77
970 SPCS2 0.45 0 0
971 PIK3AP1 0.45 13 28
972 ELL 0.44 58 121
973 UQCRFS1 0.44 — —
974 GTF3A 0.44 2 2
975 MT-ND6 0.44 — —
976 PSMD8 0.44 3 3
977 UBE2E1 0.44 0 0
978 DALRD3 0.44 4 5
979 PIH1D1 0.44 57 180
980 PCF11 0.44 0 0
981 ETS2 0.44 10 7
982 BAIAP2 0.44 15 40
983 CMPK1 0.44 12 34
984 NFKBIZ 0.44 2 3
985 NLRP3 0.44 14 61
986 SSNA1 0.44 16 44
987 ATP6AP2 0.44 — —
988 FERMT3 0.44 17 63
989 ITGB1 0.44 2 3
990 STAG2 0.44 — —
991 BRD2 0.44 256 441
992 SDHD 0.44 1 1
993 THYN1 0.44 1 1
994 KMT2E 0.44 5 10
995 LYN 0.44 11 64
996 IDS 0.44 — —
997 STK17B 0.44 5 39
998 SF3B6 0.44 4 34
999 CANX 0.44 5 6
1000 XRN1 0.43 8 24